CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model

Published:2017-12-09 Issue:69 Volume:8 Page:114095-114108
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mayr Lisa¹,Pirker Christine¹,Lötsch Daniela¹,Van Schoonhoven Sushilla¹,Windhager Reinhard²,Englinger Bernhard¹,Berger Walter¹,Kubista Bernd²

Affiliation:

1. Institute of Cancer Research and Comprehensive Cancer Center, Department of Medicine I, Medical University Vienna, 1090 Vienna, Austria

2. Department of Orthopaedics, Medical University Vienna, 1090 Vienna, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomics in orthopedic research: Recent studies and their translational implications;Journal of Orthopaedic Research;2024-06-19

2. POLE2 promotes osteosarcoma progression by enhancing the stability of CD44;Cell Death Discovery;2024-04-16

3. Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies;International Journal of Molecular Sciences;2024-03-08

4. Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells;Gene;2024-01

5. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP